IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10485811 B1

PDFFull Text
Date of Patent:
Nov. 26, 2019

Filed:

Jan. 23, 2015

Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treatinginduced inflammatory bowel diseases such as crohn's disease

Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Universite D'auvergne, Villeneuve d'Ascq, FR;

Universite Des Sciences ET Technologies DE Lille 1, Villeneuve d'Ascq, FR;

Universite DE Nantes, Nantes, FR;

Inserm Institut National DE LA Sante ET DE LA Recherche Medicale, Paris, FR;

Jean-eric Michaud, La Roche-Blanche, FR;

Pierre-yohan Michaud, Lannion, FR;

Vincent Michaud, Bordeaux, FR;

Inventors:

Julie Bouckaert, Kortrijk, BE;

Sebastien Gouin, Thouare sur Loire, FR;

Adeline Sivignon, Gerzat, FR;

Arlette Darfeuille-Michaud, La Roche-Blanche, FR;

Rostyslav Bilyy, Lviv, UA;

Dimitri Alvarez-Dorta, Nantes, FR;

Nao Yamakawa, Haubourdin, FR;

Tetiana Dumych, Volyn Oblast, UA;

Assignees:

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris, FR;

UNIVERSITE D'AUVERGNE, Clermont-Ferrand, FR;

UNIVERSITE DES SCIENCES ET TECHNOLOGIES DE LILLE 1, Villeneuve d'Ascq, FR;

UNIVERSITE DE NANTES, Nantes, FR;

INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), Paris, FR;

Attorney:

Young & Thompson

Primary Examiner:

Dale R Miller

Int. Cl.
CPC ...
C07H 15/00 (2006.01); A61K 31/7028 (2006.01); A61K 31/7056 (2006.01); A61K 31/706 (2006.01); A61K 31/724 (2006.01); C07H 15/04 (2006.01); A61K 31/7004 (2006.01); C07H 15/14 (2006.01); C07H 15/26 (2006.01); A61K 31/7064 (2006.01); A61K 31/70 (2006.01); A61K 45/06 (2006.01); C08B 37/16 (2006.01); C08L 5/16 (2006.01); A61K 9/00 (2006.01); C07H 7/02 (2006.01); C07D 405/14 (2006.01); C07D 309/10 (2006.01); C07D 309/14 (2006.01); C07D 405/12 (2006.01); A61K 47/54 (2017.01);
U.S. Cl.
CPC ...
A61K 31/70 (2013.01); A61K 9/0053 (2013.01); A61K 31/7004 (2013.01); A61K 31/706 (2013.01); A61K 31/7028 (2013.01); A61K 31/7056 (2013.01); A61K 31/7064 (2013.01); A61K 31/724 (2013.01); A61K 45/06 (2013.01); A61K 47/549 (2017.08); C07D 309/10 (2013.01); C07D 309/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07H 7/02 (2013.01); C07H 15/00 (2013.01); C07H 15/04 (2013.01); C07H 15/14 (2013.01); C07H 15/26 (2013.01); C08B 37/0012 (2013.01); C08B 37/0015 (2013.01); C08L 5/16 (2013.01);
Abstract

Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treatinginduced inflammatory bowel diseases such as crohn's disease.

Find Patent Forward Citations

Loading…